However, this effect was markedly more pronounced in ENO1‐vaccinated KPC/IL17A−/− mice, which showed significantly increased tumour area and reduced survival, compared to KPC/IL17A+/+ controls (Figure 4E,F), highlighting the pivotal role of CD8+ T cells in mediating tumour control in the absence of IL17A. Here, IL17A is linked to neoplasm.